Unknown

Dataset Information

0

Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.

ABSTRACT: In this study, a series of benzimidazole-rhodanine conjugates were designed, synthesized and investigated for their topoisomerase II (Topo II) inhibitory and cytotoxic activities. The results from Topo II-mediated pBR322 DNA relaxation and cleavage assays showed that the synthesized compounds might act as Topo II catalytic inhibitors. Certain compounds displayed potent Topo II inhibition at 10 ?M. The cytotoxic activities of these compounds against HeLa, A549, Raji, PC-3, MDA-MB-201, and HL-60 cancer cell lines were evaluated. The results indicated that these compounds exhibited strong antiproliferative activity. A good relationship was observed between the Topo II inhibitory potency and the cytotoxicity of these compounds. The structure-activity relationship revealed that the electronic effects, the phenyl group, and the rhodanine moiety were particularly important for the Topo II inhibitory potency and cytotoxicity.

SUBMITTER: Li P 

PROVIDER: S-EPMC6072309 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.

Li Penghui P   Zhang Wenjin W   Jiang Hong H   Li Yongliang Y   Dong Changzhi C   Chen Huixiong H   Zhang Kun K   Du Zhiyun Z  

MedChemComm 20180602 7

In this study, a series of benzimidazole-rhodanine conjugates were designed, synthesized and investigated for their topoisomerase II (Topo II) inhibitory and cytotoxic activities. The results from Topo II-mediated pBR322 DNA relaxation and cleavage assays showed that the synthesized compounds might act as Topo II catalytic inhibitors. Certain compounds displayed potent Topo II inhibition at 10 μM. The cytotoxic activities of these compounds against HeLa, A549, Raji, PC-3, MDA-MB-201, and HL-60 c  ...[more]

Similar Datasets

Unknown Design, synthesis and biological evaluation of imidazopyridine-propenone conjugates as potent tubulin inhibitors.
| S-EPMC6072242 | biostudies-literature
Unknown Design, Synthesis and Biological Assessment of Rhodanine-Linked Benzenesulfonamide Derivatives as Selective and Potent Human Carbonic Anhydrase Inhibitors.
| S-EPMC9697818 | biostudies-literature
Unknown Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors.
| S-EPMC7397320 | biostudies-literature
Unknown New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies.
| S-EPMC10955584 | biostudies-literature
Unknown Design, Synthesis, and Biological Evaluation of 1,2,3-Triazole-Linked Triazino[5,6-B]Indole-Benzene Sulfonamide Conjugates as Potent Carbonic Anhydrase I, II, IX, and XIII Inhibitors.
| S-EPMC7281265 | biostudies-literature
Unknown Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.
| S-EPMC2538619 | biostudies-literature
Unknown Design, synthesis, and <i>in vitro</i> biological evaluation of novel benzimidazole tethered allylidenehydrazinylmethylthiazole derivatives as potent inhibitors of <i>Mycobacterium tuberculosis</i>.
| S-EPMC6349066 | biostudies-literature
Unknown Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation.
| S-EPMC3370419 | biostudies-literature
Unknown Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors.
| S-EPMC2838169 | biostudies-literature
Unknown Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.
| S-EPMC7125537 | biostudies-literature